Simple versus informed choice invitations to screening

ISRCTN ISRCTN73125647
DOI https://doi.org/10.1186/ISRCTN73125647
Secondary identifying numbers 076838
Submission date
23/12/2005
Registration date
09/01/2006
Last edited
21/12/2012
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Theresa Marteau
Scientific

Psychology Dept. (at Guy's)
Health Psychology Section
Psychology & Genetics Research Group
5th Floor Thomas Guy House
Guy's Campus
London Bridge
London
SE1 9RT
United Kingdom

Phone +44 (0)20 7188 0192
Email theresa.marteau@kcl.ac.uk

Study information

Study designMulticentre single-blind randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typeScreening
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleDidactic versus informed choice invitations to screening: balancing public health benefits and individual choice
Study acronymDICISION
Study objectivesWe propose to develop a feasible and effective informed choice strategy and to evaluate its impact on attendance at screening and motivation to follow subsequent advice, both overall and stratified by social deprivation. The work is set within the important public health context of screening for type two diabetes. We will test two hypotheses:
1. Uptake of screening for diabetes is higher following a traditional, didactic invitation compared with an informed choice invitation.
2. Amongst those who attend for screening, intentions to change behaviour to reduce risks are stronger following an informed choice invitation compared with a traditional invitation.
Ethics approval(s)Cambridgeshire 1 Research Ethics Committee gave approval on the 5th May 2006 (ref: 06/Q0104/17)
Health condition(s) or problem(s) studiedInformed choice for screening for type two diabetes
Intervention1. Traditional invitation:
This will be a brief letter based on previous invitations for screening tests, including diabetes and coronary heart disease. It will include:
a. name of the condition i.e. type two diabetes
b. aims of screening i.e. to reduce risks of diabetes and associated cardiovascular disease
c. procedure i.e. review of risk including blood tests and clinical measures, advice and treatment as indicated

2. Informed choice invitation:
This will comprise the same brief letter but with additional detailed information based on General Medical Council (GMC) guidelines, and linked to a self-administered informed choice aid based on similar tools successfully used to facilitate personal decisions in other health care contexts.
Intervention typeOther
Primary outcome measureUptake of screening, which will be recorded by the practice nurses conducting the screening.
Secondary outcome measures1. Intention to change behaviour to reduce risks of diabetes: behavioural intentions are good predictors of behaviour change. Three core behavioural intentions will be assessed in those attending:
a. increasing physical activity
b. restricting calories by eating low fat foods
c. taking preventive medication, if indicated
d. stopping smoking will also be assessed, when relevant
2. Self-reported behaviour assessed using standard questionnaires:
a. physical activity
b. diet
c. smoking and use of medication to reduce risk of diabetes
3. Attendance for post screening blood tests and subsequent practice nurse advice will be recorded
4. Social deprivation: area (post code) and individual level measures (education, home ownership and access to car) will be used. Age, gender, and ethnic group and risk factors known before screening will also be recorded.
5. Risk stratification: all those attending will be given a risk score to indicate their risks of developing diabetes and experiencing a cardiovascular event over the next ten years. Those with confirmed diabetes, expected to be about 30 individuals, will also receive their Coronary Heart Disease (CHD) risk scores
6. Informed choice: choices to participate in screening will be classified as informed to the extent that they are based on understanding diabetes screening and reflect the decision-maker’s values, using a standardised method we have developed and validated in other screening contexts
Overall study start date01/01/2006
Completion date31/12/2007

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants1200 - but the study is sufficiently powered at 585
Key inclusion criteria1. 1200 men and women aged 40 to 69 years
2. In the top 20% of risk of undiagnosed diabetes on practice registers, defined by a validated risk score applied to routine data on general practice population registers. The Cambridge Diabetes Risk Score includes the following risk variables:
a. age
b. gender
c. family history of diabetes
d. smoking status
e. prescription of steroid or anti-hypertensive medication
f. body mass index
Key exclusion criteriaPatients considered by the practice nurse or General Practitioner to be unsuitable for the project, for example, people who are severely ill, will be excluded from the study.
Date of first enrolment01/01/2006
Date of final enrolment31/12/2007

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Psychology Dept. (at Guy's)
London
SE1 9RT
United Kingdom

Sponsor information

King's College London (UK)
University/education

Institute of Psychiatry
De Crespigny Park
London
SE5 8AF
England
United Kingdom

Email g.dale@iop.kcl.ac.uk
ROR logo "ROR" https://ror.org/0220mzb33

Funders

Funder type

Charity

The Wellcome Trust (UK) (ref: 076838)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 20/02/2009 Yes No
Results article results 13/05/2010 Yes No
Results article results 01/09/2011 Yes No